Areas of Focus
- Clinical and basic research of malignant lymphoma
- Clinical and basic research of multiple myeloma
Work Experience
- 2017/12–Present - University of Science and Technology of China, First Affiliated Hospital - Chief Physician
Academic Background & Achievements
- 2003/09–2006/07 Doctorate in Internal Medicine: Suzhou University
Publications
- Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma, Wang X, Yu L, Jiang X, Ding K, 2023
- Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial, Ding K, Liu H, Ma J, et al., 2023
- Identifying tumor antigens and immune subtypes of gastrointestinal MALT lymphoma for immunotherapy development, Jiang X, Zhang H, Ni J, Zhang X, Ding K, 2022
- The 'm6A writer' METTL3 and the 'm6A reader' IGF2BP2 regulate cutaneous T-cell lymphomas progression via CDKN2A, Wang X, Hu M, Yu L, Wang X, Jiang X, Zhang G, Ding K, 2022
- Roles of exosomes in cancer chemotherapy resistance, progression, metastasis and immunity, and their clinical applications (Review), Zhou Y; Ding K; Wang X, 2021